Extract
The present study using immunologic methodology confirms previous obserrations from this laboratory of an absence of a protease component with arginine esterase activity in plasma of patients with cystic fibrosis. In this study, the pooled plasma from control individuals was activated and partially purified after adsorption on columns of soybean trypsin inhibitor conjugated to Sepharose 4B followed by elution with benzamidine. The fraction was further purified by isoelectrofocusing on polyacrylamide gels. Proteins around the pI range of 5.5 were eluted and utilized to prepare an antiserum. Immunoelectrophoresis of activated plasma samples irom control subjects and patients with cystic fibrosis was performed utilizing the antiserum. In controls, four precipitin arcs with residual esterase activity were observed, whereas only three were seen in plasma from patients with cystic fibrosis. Double gel diffusion experiments using specific antisera ruled out the presence of trypsin, chymotrypsin, plasminogen, prothrombin, C1 esterase, a,-trypsin inhibitor, and inter-a-trypsin inhibitor in the concentrated benzamidine eluate.. The antisera to a,-macroglobulin gave an immunoprecipitate which was readily stained for proteolytic activity. On immunoelectrophoresis, the a,-macroglobulin precipitin band corresponded to the band absent in plasma of patients with cystic fibrosis. In contrast, the a,-macroglobulin levels were similar in plasma of control subjects and patients with cystic fibrosis. Using the antiserum to the protein fraction with a pI of 5.5 in cross immunoelectrophoresis, three "rockets" with proteolytic activity could be demonstrated in control plasma. One specific enzymeactive "rocket" was absent in plasma of patients with cystic fibrosis. In a double blind study of 15 control samples and 15 samples from patients with cystic fibrosis, a specific "rocket" was shown to be present in 13 control samples and absent in 14 cystic fibrosis samples. a,-Macroglobulin was determined by both an immunologic procedure and by its trypsin binding (trypsin protein esterase concentration). The ratio of the immunologic assay to the biologic activity assay was 90 for the normal plasma samples and only 65 for cystic fibrosis samples.
Speculation
The absent a,-macroglobulin-protease complex in plasma of patients with cystic fibrosis might reflect a molecular defect in either a protease with arginine esterase activity or within the a,-macroglobulin molecule.
Previous studies have shown that saliva and plasma of patients with cystic fibrosis are deficient in a proteolytic activity with arginine esterase substrate specificity (18) (19) (20) (21) . Subsequent studies have documented the proteolytic nature of this arginine esterase activity (20) . On the basis of these observations, we have speculated that the deficiency of proteolytic activity could explain the presence of several cationic macromolecular "factors" reported to be present in saliva (16) and plasma (4, 5, 25) of patients with cystic fibrosis.
Previous studies of arginine esterase have employed enzymologic, chromatographic, and isoelectrofocusing techniques. In this report, utilizing an immunologic methodology, we demonstrate the absence of an enzyme, a,-macroglobulin complex in plasma of patients with cystic fibrosis.
EXPERIMENTAL PROCEDURE M A T E R I A L S
Soybean trypsin inhibitor (STI) type 11-S (lot 34C-8180) used for affinity chromatography; trypsin inhibitor type I-S (chromatographically prepared, lot 85C-8055) used for inhibition studies; bovine trypsin type 111 twice crystallized (lot 21C-0140); a-Nbenzoyl-DL-arginine-8-naphthylamide-HCI (BANA, lot 44C-0880); a-N-benzoyl-L-arginine ethyl ester-HC1 (BAEE, lot 94C-0006-2); a-N-benzoyl-DL-arginine-p-nitroanilide-(BAPNA, lot 124C-0292); o-dianisidine, tetrazotized (lot 64C-01012); and p-hydroxymercuribenzoate (Na salt, lot 97B-5200) were all obtained from Sigma Chemical Company (St. Louis, Mo.). Benzamidine hydrochloride hydrate (lot 11 1757) was purchased from Aldrich Chemical Company, Inc. (Milwaukee, Wis.). Agarose was procured from Marine Colloids, Inc. (Rockland, Ma.), and Sepharose 4B was obtained from Pharmacia Fine Chemicals, Inc.
(Piscataway, N. J.). All other materials used were reagent grade or the best grade available.
Specific rabbit antisera to human whole serum, albumin, a,-antitrypsin, a,-macroglobulin, inter-cu-trypsin inhibitor, plasminogen, prothrombin, and complement component C1 esterase (Cls) were all purchased from Behring Diagnostics (Somerville, N. J.). Specific rabbit antisera to human trypsin and chymotrypsin were prepared as previously described (22, 24) .
The hydrolysis of BAEE (0.05 M in 0.15 M NaCI) at 37O was followed by an autotitrator (Radiometer Co., model SBR C2) with a 0.25 ml autoburette (ABU 12) and combined electrode (GK 2302C) using 0.05 M NaOH. The specific activity is expressed as micromoles per hr per mg protein and is referred to as arginine esterase (AE) activity.
The enzymatic activity towards BAPNA was determined spectrophotometrically (Beckman DB with 1 cm light path) according to Erlanger et a/. (6) .
The residual enzymatic activity of the immunoprecipitin line towards BAEE was performed as previously described for human trypsin immunoprecipitates (22) . The activity of these precipitin lines towards BANA was determined as follows. Four milligrams of BANA and 40 mg o-dianisidine were dissolved in 0.5 ml dimethyl-formamide and 9.5 ml warmed (45") phosphate buffer 0.2 M, pH 7.6, were added. This substrate solution was applied on the washed plate containing the immunoprecipitate at 38' for 1-3 hr in a humid chamber. Activity was observed when dark brown
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Polyacrylamide gel electrofocusing was performed at 4" with dual vertical slab gel, 3 mm thickness (Bio-Rad model 220) in 7.5% acrylamide (C = 2.5%) (Eastman-Kodak) containing 1% ampholine (LKB, pH range 4-8). with constant voltage (150 V ) for 16 hr. A marginal strip was cut from both sides of the slab and the pH gradient was measured in I-cm intervals. When the slabs were stained for protein, they were first immersed overnight in 10% trichloroacetic acid and stained with 1 % amido black in 10% acetic acid.
When this procedure was used for the preparation of protein fractions, the slab was scanned at 280 nm with a scanning densitometer (Transidyne General, Ann Arbor, Mich.) and the protein bands removed. The acryl band with the protein fraction was homogenized with a glass hand homogenizer, dispersed in 3 ml saline, and dialyzed overnight against saline. The acrylamide was removed by centrifugation and the protein content determined according to the method of Lowry et a/. (14) .
Immunization. Two rabbits were each immunized with 2 mg protein antigen in complete Freund's adjuvant (Difco) at multiple intradermal sites. Starting 10 days after immunization, the rabbits were bled weekly from the marginal ear vein. Antibody content of some of the individual bleedings was determined by a quantitative precipitin test (10) and was found to be 2.0--2.5 mg/ml. Antibody titer remained at this level for several months without the need for a booster injection. The antisera were pooled and the IgG fraction was prepared according to the method of Levy and Sober ( 1 3).
. .
Double diffusion in agar gel, 1% in phosphate-buffered saline (PBS), was carried out according to the procedure of Ouchterlony (17) . The plates were washed exhaustively with PBS, pH 7.4, the precipitin lines were photographed, and the residual enzymatic activity was demonstrated towards either BAEE or BANA. Immunoelectrophoresis was carried out in 0.05 M barbital buffer, pH 8.6, using agarose-coated sheets (Bioware, Inc., Wichita, Kan.) with a constant voltage of 8 V/cm for 2.5 hr. The plates were washed exhaustivelv in PBS and the precivitin arc stained for . . either protein by amido black or for residual enzymatic activity towards BANA.
Cross immunoelectrophoresis was performed according to the method of Laurel1 (12) as follows. The IgG fraction of the antiserum was added to 40 ml 0.75% agarose in 0.05 M bal-bital buffer, pH 8.6, cooled to 48O to a final concentration of 0.2 mg/ml (or in some experiments, 0.15 mg/ml). The solution was gently mixed and poured on glass plates (10 by 20 cm) and stored at 4" overnight. Wells (3.2 mm diameter) 1 cm apart were punched out and the samples (7 ~1 ) applied. Electrophoresis with a constant voltage of 6 V/cm was performed using the same buffer for 12 hr. The plates were washed for 24 hr against PBS and the residual enzymatic activity towards BANA was determined.
0,-MACROGLOBULIN D E T E R M I N A T I O N
The immunologic determination was carried out by single radial immunodiffusion according to Mancini et al. (15) in a fashion similar to that previously described for trypsin quantitation (22) . The anti-cu,-macroglobulin antiserum final concentration in the agarose was 2%. The plasma samples applied for determination were diluted v/v with PBS and 6 were applied in duplicate. Four serial dilutions of pooled serum with a known a,-macroglobulin concentration were used for the standard curve. The diffusion was completed at 38'. The washed plates were stained for residual BAEE activity. The concentration as reflected by bovine trypsin binding was carried out according to the method of Gannot (7) and expressed as micromoles of BAPNA hydrolyzed per hr by trypsin bound to I mg sample protein.
CNB~-;ctivated Sepharose 4B according to the method of Axen e; al.
(1). The binding yields in different preparations were found to be 65-75%. The affinity adsorbent was washed exhaustively on a Buchner funnel with PBS until no protein could be detected when following absorbance of the eluates at 280 nm. The protein fraction obtained after fractionation at 50% (NH,),SO, was dialyzed against PBS. Then 1,200 ml (protein, 60 mg/ml) were added to the semidry cake and stirred overnight at 4". The nonadsorbed fraction was separated on a Buchner funnel and the cake washed first with 4 liters PBS and 6 liters 0.1 M phosphate buffer, pH 7.0, containing 0.4 M NaCI. The absorbance of the effluent at 280 nm after the washing was less than 0.02. The adsorbed fraction was eluted by stirring the adsorbent at 38" with 500 ml of the last buffer solution containing 0.5 M benzamidine. The eluate was dialyzed for 24 hr against saline and concentrated by negative pressure ultrafiltration.
ACTIVATED P L A S M A F R A C T I O N S
Blood samples obtained from 15 healthy individuals and 15 cystic fibrosis patients were activated by chloroform-ellagic acid and handled as previously described (19) . An equal volume of saturated (NH,),SO, solution, pH 7.0, was added and the samples stirred and kept at 4' overnight. The precipitate separated by centrifugation was washed three times with 50% saturation (NH,),SO, solution, suspended in a minimal volume of distilled water, and dialyzed at 4" for 48 hr against PBS. The samples were centrifuged at 22,000 x g for 30 min. After determination of the enzymatic activity towards BAEE, the samples were stored at -20". Pooled normal plasma from healthy blood donors was obtained from blood banks and activated in a similar fashion. Normal plasma from nine healthy blood donors (2,600 ml) was activated by chloroform-ellagic acid treatment. An aliquot ( I 0 ml) was dialyzed against saline for further studies and the remainder precipitated by (NH,),SO, at 50% saturation, pH 7.0. The precipitate was washed with 50% (NH,),SO, solution and dialyzed exhaustively against PBS. This fraction of the activated plasma was designated as A E I. The fraction was applied for affinity chromatography on 7 g ST1 insolubilized on Sepharose 4B and eluted with 0.5 M benzamidine. The fraction obtained by ST1 affinity chromatography was designated as A E 11. The protein content and the enzymatic activity towards BAEE of the three fractions is summarized in Table I . The heterogeneity of the enzymatic activity in all fractions is evident from the different increases of the specific activity when determined at various pH values.
The pH profile of the partially purified A E preparation (AE 11) is shown in Figure I . A bimodal profile was obtained with one pH optimum at pH 7.4 and the second at pH above 8.5. In an attempt to separate the various enzyme components of A E 11, this protein fraction was subjected to heat inactivation. The results are shown in Figures I and 2 . It is shown that the enzyme component with the more basic pH optimum was more heat labile whereas the component with a pH optimum of p H 7.4 was relatively heat stable. N o apparent inhibition of A E 11 activity towards BAEE was observed by p-hydroxymercuribenzoate at concentrations of 10-4-10-" whereas ST1 (100 ,.g/ml) inhibited 87% of the activity.
A E I1 was examined by double gel diffusion against monospecific antisera to human trypsin, chymotrypsin, plasminogen, prothrombin, and C1 esterases, all proteases with arginine esterase activity. An antigenically cross-reacting material was shown only with the antisera to plasminogen. T o rule out the possibility that enzymes might be present in the A E I1 fraction as complexes with various serum protease inhibitors, it was examined by double gel diffusion against antisera to a,-trypsin inhibitor, inter-a-trypsin inhibitor, and a,-macroglobulin. Only the anti-N,-macroglobulin antiserum gave an immunoprecipitate with residual enzymatic activity towards both BAEE as well as towards BANA.
Further characterization of the protein components of A E 11 was obtained by immunoelectrophoresis with different antisera. As seen in Figure 3A , precipitin arcs were observed with anti-human I A E S Fig. 3 . A: immunoelectrophoresis of (NH,),SO, precipitate of activated plasma AE I and of partially purified arginine esterase AE 11 with the following antisera: anti-human serum proteins (a.THS); anti-albumin (a.HSA); anti-IgG (a.HlgG); anti-a,-macroglobulin (a.Ha,M); and antiplasminogen (a.HPlas.). B: residual a-N-benzoyl-DL-arginine-P-naphthylamide-HCI activity in some of the imniunoprecipitates. serum albumin, anti-human IgG, anti-human a,-macroglobulin, and anti-human plasminogen. In Figure 3B , the residual enzymatic activity of some of these arcs is shown.
P R E P A R A T I O N O F A N T l A R G l N l N E ESTERASE A N T I S E R U M
When the A E I1 protein fraction was subjected to isoelectrofocusing on polyacrylamide slab gel, numerous protein components were observed (Fig. 4) . Twenty milligrams of A E I1 were applied for preparative polyacrylamide slab isoelectrofocusing. When the slab was scanned at 280 nm, four very close protein bands were shown in the area of pH 5.5. The acrylamide band containing this fraction was removed and used for immunization. The antiserum thus obtained was designated as anti-AE. The IgG fraction of this antiserum was prepared. The antiserum (anti-AE) was examined against A E I1 and compared with antisera against human IgG and human a,-macroglobulin by double gel diffusion (Fig. 5) . A precipitin line forming a spur formation with the other antisera and revealing enzymatic activity was observed.
When activated plasma samples of normal individuals and cystic fibrosis patients were examined by immunoelectrophoresis with this antiserum, four precipitin arcs with enzymatic activity were shown in the healthy donor samples whereas only three were shown in the cystic fibrosis samples (Fig. 6 ). As seen in this figure, the IgG arc with residual enzymatic activity was faint for both the cystic fibrosis and normal plasma samples. The arc missing in the cystic fibrosis samples is the one corresponding to the a,-macroglobulin of Figure 3 .
C O M P A R I S O N O F N O R M A L A N D C Y S T I C FIBROSIS-ACTIVATED P L A S M A S A M P L E S
Fifteen plasma samples from healthy donors and 15 from cystic fibrosis patients were activated and the 50% saturation (NH4),S0, fraction prepared. The enzymatic activity towards BAEE is summarized in Table 2 . As observed before, this activity had components with different heat stabil~ty. Therefore, the fractions were compared with their residual activity after heat inactivation. As shown in the table, the samples from patients with cystic fibrosis revealed a lower enzymatic activity that was relatively heat stable as compared with normal but marked overlaps were found.
Since the activity missing in cystic fibrosis was associated with the enzyme-a,-macroglobulin complex, we investigated the possibility that "enzyme-free" az-macroglobulin might be present in higher concentration in the activated plasma fractions from cystic fibrosis samples. In order to measure this component, the binding of bovine trypsin to free a,-macroglobulin was determined by measuring its residual activity towards BAPNA in the presence of ST1 (trypsin protein esterase concentration). As shown in Table 2 , the mean value of both 0,-macroglobulin and trypsin protein esterase concentration in the cystic fibrosis group was relatively higher. When the ratio of a,-macroglobulin determinations by both procedures was calculated (Table 2 ), a lower ratio was shown in the cystic fibrosis group. Moreover, when these plates were washed exhaustively and the residual enzymatic activity towards BAEE of the precipitin rings was examined, marked qualitative differences were observed. Although both the normal and cystic fibrosis precipitin rings had some residual activity, the activity Fig. 5. Residual enzymatic activity (a-N-benroyl-DL-arginine-b-napthylamide-) of the immunoprecipitates obtained by double gel diffusion of partially purified arginine esterase. The antisera are designated as in Figure 3 . Fig. 6 . Residual enzymatic activity (a-N-benzoyl-DL-arginine-P-napthylamide-HI) of the immunoprecipitates obtained by immunoelectrophoresis of normal (N) and cystic fibrosis (CF) (NH,),SO, precipitates of activated plasma. Anti-AE 11 has been applied to the slots. ' Micromoles of a-N-benzoyl-DL-arginine-p-nitroanilide-HI hydrolyzed per h r by trypsin bound to I mg sample protein Immunologic determination.
staining was fainter and appeared later in the rings of cystic fibrosis samples. As shown previously, an immunoprecipitin arc with enzymatic activity was missing on immunoelectrophoresis in the cystic fibrosis samples (Fig. 6) . The reproducibility of this observation in a double blind study revealed subjective problems in the definite documentation and made it impractical for use in individual clinical samples. Distinction between cystic fibrosis and normal became obvious by using immunoelectrophoresis in agarose containing antibodies (cross immunoelectrophoresis). Using this technique with agarose containing 0.2 mg/ml anti-AE IgG fraction, three coinciding "rockets" were observed when the washed plates were stained for BANA enzymatic activity. The usual symmetry observed in such "rockets" as well as the correlation between concentration and rocket length was not obtained with our enzymatic activity staining. One of these "rockets" was missing in the cystic fibrosis samples (Fig. 7A) . In lower antibody concentrations (0.15 mg IgG/ml) only that one "rocket" missing in cystic fibrosis could be shown (Fig. 7B) . A faint "rocket" of immunoprecipitate with no residual enzymatic activity was seen in the cystic fibrosis samples. When I5 normal samples and 15 cystic fibrosis samples were examined in a double blind fashion, 13 out of 15 healthy individual samples demonstrated this "rocket," whereas in 14 out of 15 cystic fibrosis samples, it was absent.
DISCUSSION
The present study using an immunologic methodology confirms previous observations from our laboratory of an absence of a protease component with arginine esterase activity in plasma of patients with cystic fibrosis (19, 20) . Since previous studies had shown that this enzyme fraction is ST1 inhibited (19) (20) (21) , we utilized affinity chromatography on ST1 as the approach for partial purification. The protein fraction obtained from activated plasma contained only one recognizable proteolytic enzyme, plasmin, in detectable concentrations (Fig. 3) . The three other protein components with arginine esterase activity cross-reacted antigenically with commercially available antisera to human serum albumin, IgG, and 0,-macroglobulin. This partially purified arginine esterase preparation (AE 11) was subjected to isoelectrofocusing (Fig. 4) and the protein fraction, pI 5.5, was used for immunization. The antiserum thus obtained revealed three distinct immunoprecipitates with residual enzymatic activity corresponding to those previously mentioned. N o antibodies directed against plasmin could be demonstrated in this antiserum (anti-AE). The precipitin arc with residual enzymatic activity identified as serum albumin can be explained by the diversity of its nonspecific ligand binding affinities (I I). Thus, such complexes could be adsorbed to the ST1 chromatography by the proteolytic enzyme specificity. We presume that the second precipitin arc with arginine esterase activity that is antigenically cross-reacting with IgG might represent kallikrein. Since the two proteins, IgG and kallikrein, are so closely associated, antiserum prepared against the purified enzyme had t o be adsorbed with Fletcher factor-deficient plasma or with purified IgG (2) . The third antigenic component in A E I1 with an Fig. 7 . Residual enzymatic activity (cu-N-benzoyl-DL-arginine-P-napthylamide-HC1) of immunoprecipitates obtained after electrophoresis of normal (N) and cystic fibrosis (CF)-activated plasma in agarose containing anti-A€ 11 antibodies. I n the upper plate (A), the concentration of the IgG fraction of anti-AE 11 was 0.2 mg/ml agarose. The concentration in plate B was 0.15 rng/ml agarose.
isoelectric point of 5.5 was found to be antigenically an 0,-macroglobulin (Fig. 3 A ) that exhibits arginine esterase activity (Figs. 3B and 5). This enzymatic activity associated with an 0,-macroglobulin complex was shown to be deficient by both immunoelectrophoresis (Fig. 6 ) and immunoelectrophoresis in agarose containing antibodies (Fig. 7 ) in 14 out of 15 cystic fibrosis sera.
Recently, Wilson and Fudenberg (26), using multiple chromatographies, gel filtration, and starch block electrophoresis, documented that a protein fraction with a pl of 5.5, a,-macroglobulin, was absent in plasma from cystic fibrosis patients. As in our observation, they also found a normal concentration of antigenically cross-reacting a,-macroglobulin in cystic fibrosis and slightly reduced binding capacity for trypsin (Table 2) . They suggested that this protein is an a,-macroglobulin "proteolytic subunit derivative" and not a plasma protease as "plasma proteases do not have pI values near 5.5." However, in our study, the plasma fraction with a pI of 5.5 was obtained by its protease specificity toward the inhibitor STI. The residual enzymatic activity of this protein component in an immune complex with its specific antibodies could be demonstrated (Figs. 3, 4, and 7) . Based on this observation, we suggest that the observed phenomenon of a missing protein with pI of 5.5 is secondary to an absence of an 0,-macroglobulin-protease complex or an a,-macroglobulin subunitprotease complex. The spur formation observed with A E 11 antigens in double gel diffusion against the anti-AE antiserum and the commercial anti-a,-macroglobulin (Fig. 5 ) indicates that only some of the antigenic determinants of a,-macroglobulin were immunogenically expressed when this fraction was used for immunization. This observation suggests that in the a,-macroglobulin-protease complex a number of antigenic determinants were altered and, therefore, the possibility of a,-macroglobulin subunits is likely.
It was shown that a,-macroglobulin (3, 8, 9) binds and inhibits essentially all endopeptidases in approximately equimolar ratio and does not react with exopeptidases and nonproteolytic hydrolases. The proteolytic enzyme cleaves a peptide bond in the 0,-macroglobulin molecule irreversibly. An entrapped a,-macroglobulin presumably binds only proteases in their active enzyme form (3) . The present study and that of Wilson and Fudenberg (26) demonstrate no difference in cu,-macroglobulin concentration in plasma of control subjects and patients with cystic fibrosis. Therefore, the study is consistent with the hypothesis that the absence of the a,-macroglobulin-protease complex reflects a molecular defect in either of the two components as originally suggested by Wilson and Fudenberg (26) . More recent studies in our laboratory have shown that the a,-macroglobulin molecule is altered in patients with cystic fibrosis and obligate heterozygotes (23).
S U M M A R Y
The present study using immunologic methodology confirms previous observations from our laboratory of an absence of a protease component with arginine esterase activity in plasma of patients with cystic fibrosis. Arginine esterase in plasma from normal individuals was partially c h a k t e r i z e d , subjected to isoelectrofocusing, and the plasma fraction with a p1 of 5.5 used for the preparation of antisera. The antisera obtained revealed four distinct immunoprecipitates with residual enzymatic activity in normal subjects, whereas only three immunoprecipitates were seen in plasma of cystic fibrosis patients. The precipitin arcs with the residual enzymatic activity were identified. One arc with enzymatic activity was found to be antigenically an a,-macroglobulin. The enzymatic activity associated with the a,-macroglobulin complex was shown to be deficient by both immunoelectrophoresis and immLnoelectrophoresis with agarose containing antibodies in 14 out of 15 patients with cystic fibrosis. In contrast, in 13 of 15 normal individuals, this a,-macroglobulin-protease complex was readily demonstrated. These results are consistent with our earlier demonstration of a deficiency of proteolytic activity in cystic fibrosis and suggest that this activity is apparently complexed with a,-macroglobulin.
